Guillain-Barré syndrome diagnostic criteria: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Guillain-Barré syndrome}} {{CMG}}; '''Associate Editors-In-Chief:''' Priyamvada Singh, MBBS [mailto:psingh13579@gmail.com] ==Overview== '''...")
 
No edit summary
Line 4: Line 4:
{{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, MBBS]] [mailto:psingh13579@gmail.com]
{{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, MBBS]] [mailto:psingh13579@gmail.com]


==Overview==
'''Guillain-Barré syndrome''' ('''GBS''') is an acute, autoimmune, [[neuropathy|polyradiculoneuropathy]] affecting the [[peripheral nervous system]], usually triggered by an acute infectious process. It is included in the wider group of [[peripheral neuropathy|peripheral neuropathies]].
==Diagnostic criteria==
==Diagnostic criteria==
* '''Required'''
* '''Required'''
Line 35: Line 33:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Needs overview]]

Revision as of 17:37, 5 December 2012

Guillain-Barré syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Guillain-Barré syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Guillain-Barré syndrome diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Guillain-Barré syndrome diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Guillain-Barré syndrome diagnostic criteria

CDC on Guillain-Barré syndrome diagnostic criteria

Guillain-Barré syndrome diagnostic criteria in the news

Blogs on Guillain-Barré syndrome diagnostic criteria

Directions to Hospitals Treating Guillain-Barré syndrome

Risk calculators and risk factors for Guillain-Barré syndrome diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]

Diagnostic criteria

  • Required
    • Progressive, relatively symmetrical weakness of 2 or more limbs due to neuropathy
    • Areflexia
    • Disease course < 4 weeks
    • Exclusion of other causes (see below)
  • Supportive
    • relatively symmetric weakness accompanied by numbness and/or tingling
    • mild sensory involvement
    • facial nerve or other cranial nerve involvement
    • absence of fever
    • typical CSF findings obtained from lumbar puncture
    • electrophysiologic evidence of demyelination from electromyogram

References

Template:WH Template:WS